Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 7 Oct 2007):

[Impact of sirolimus on collagen synthesis in vascular smooth muscle cells: experiment with rat]

Full Abstract

OBJECTIVE: To evaluate effects of sirolimus on collagen synthesis and collagen type I and type III mRNA expression in vascular smooth muscle cells (VSMCs). METHODS: Rat VSMCs from thoracic aorta were cultured and added with sirolimus of the concentrations of 0, 0.1, 1.0, 10, and 100 ng/ml respectively for 24 h, then co-cultured with L-(3)H-proline for 12 h. L-(3)H-proline incorporation was monitored by liquid scintillation counting. RT-PCR was used to detect the mRNA expression of collagen type I and collagen type III. Logarithmic phase VSMC were treated with sirolimus by 0 ng/ml, 0.1 ng/ml, 1 ng/ml, 10 ng/ml and 100 ng/ml respectively for 24 h prior to 12 h exposure to L-(3)H-proline. RESULTS: The proline incorporation values were 1369 +/- 186, 1211 +/- 157, 1037 +/- 139, 910 +/- 144, and 741 +/- 160 cpm respectively of the 0, 0.1, 1, 10, and 100 ng/ml sirolimus groups. Paired t-test analysis showed that the proline incorporation value of the group with higher sirolimus concentration was significantly lower than that of the group with lower sirolimus concentration (F = 18.936, P < 0.001), except between the 0.1 ng/ml group and 0 ng/ml group (control group) and between the 1 ng/ml group and 10 ng/ml group (P = 0.057, P = 0.12). RT-PCR showed that the collagen I levels were 112 +/- 23, 140 +/- 23, 152 +/- 12, 166 +/- 22, and 179 +/- 18 respectively in the groups of sirolimus of the concentrations of 100, 10, 1, 0.1, and 0 ng/ml respectively, the higher the concentration of sirolimus the lower the collagen I level (all P < 0.05), however, there was no significant difference in the collagen I level between the 0.1 mg/ml group and the control group (P = 0.236). There was no significant difference in the collagen III level among the groups of sirolimus of different concentrations (F = 2.409, P = 0.070). CONCLUSION: Sirolimus inhibits the collagen synthesis in the VSMCs and attenuates the mRNA expression of type I collagen concentration-dependently.

 

Author information

Author/s: Li, Jia-Ping (JP); Yang, Jian-Yong (JY); Chen, Wei (W); Zhuang, Wen-Quan (WQ); Wang, Jian-Bo (JB);

Affiliation: Department of Interventional Radiology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.

Journal and publication information

Publication Type: English Abstract; Journal Article

Journal: Zhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi), published in China. (Language: chi)

Reference: 2007-Oct; vol 87 (issue 37) : pp 2653-6

Dates: Created 2007/12/28; Completed 2008/06/30;

PMID: 18162157, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Collagen Type I (0) ; Collagen Type III (0) ; RNA, Messenger (0) ; Sirolimus (53123-88-9)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

1/30/1999
3/5/2008
Higher Relevance Score (52)
Lower Relevance Score (31)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index